Restelli, U., Alberti, A., Lazzarin, A., Bonfanti, M., Nappi, C., & Croce, D. (2016). Budget impact analysis of the use of daclatasvir in Italy for the treatment of Hepatitis C Virus (HCV) genotype 3 patients. Farmeconomia. Health Economics and Therapeutic Pathways, 17(1), 7–12. https://doi.org/10.7175/fe.v17i1.1225